Dr Sunir Garg reflects on the recent American Academy of Ophthalmology meeting in Orlando and expresses excitement on how artificial intelligence (AI) can be used to detect, treat, and transform the ...

Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...

New research finds that retinal diseases thought to map one-to-one to genetic mutations are more complicated than that.

Retinal disorders can severely impact vision if left untreated. Early detection is crucial for conditions like Diabetic Retinopathy, Age-Related Macular Degeneration, Retinal Detachment, Glaucoma, and ...

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...

Researchers at the Indian Institute of Technology, Madras, have identified a method to treat retinal tears and diabetic retinopathy. They used mild laser-induced convection to enhance the delivery of ...

RetinaDA unites six public fundus sets into a 512 × 512 macula-centered benchmark with built-in domain gaps, enabling ...

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other ...

EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...